# A Three Part Study of MGV354 in Ocular Hypertension or Glaucoma

> **NCT02743780** · PHASE1,PHASE2 · COMPLETED · sponsor: **Alcon Research** · enrollment: 191 (actual)

## Conditions studied

- Ocular Hypertension
- Open-Angle Glaucoma

## Interventions

- **DRUG:** MGV354 ophthalmic suspension
- **DRUG:** MGV354 placebo

## Key facts

- **NCT ID:** NCT02743780
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-02
- **Primary completion:** 2016-09-20
- **Final completion:** 2016-09-20
- **Target enrollment:** 191 (ACTUAL)
- **Last updated:** 2018-07-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02743780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02743780, "A Three Part Study of MGV354 in Ocular Hypertension or Glaucoma". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT02743780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*